LymphomaArchives
Safety and efficacy of bridging radiation therapy prior to CD19 CAR T for non-Hodgkin lymphoma: a systematic review and meta-analysis
Lymphoma 1 min.
Bridging radiation therapy (BRT) is increasingly utilized prior to CD19-directed chimeric antigen receptor T cells (CART19) in patients with non-Hodgkin lymphoma (NHL). However, its impact on outcomes of CART19 therapy is not established. We conducted a systematic review and meta-analysis to estimate...
Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment forTropheryma whipplei
Lymphoma 1 min.
Extranodal marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma) is an indolent lymphoma that accounts for approximately 7-8% of newly diagnosed lymphomas. MALT lymphoma most commonly originates from the stomach while extra-gastric MALT lymphoma is located most frequently in...
Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry study
Lymphoma 1 min.
The presence of a single large site of disease or so-called tumor 'bulk' in lymphoma has been variably associated with outcomes and influenced management decisions. However, challenges arise in using bulk as a prognosticator due to varied definitions across different lymphoma subtypes but also within...
PD-1–based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma
Lymphoma 1 min.
Combination therapy incorporating programmed cell death protein 1 (PD-1) blockade results in unprecedented response rates in both frontline and relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL). Previous retrospective studies have suggested benefit for PD-1 blockade before autologous stem cell...
